INTESTINAL TRACT PROTECTANT AND INTESTINAL TRACT PROTECTION METHOD, PHARMACEUTICAL, FOOD AND DRINK AND TIGHT JUNCTION-ASSOCIATED FACTOR EXPRESSION PROMOTER

PROBLEM TO BE SOLVED: To provide a novel intestinal tract protectant and intestinal tract protection method, pharmaceutical, food and drink and tight junction-associated factor expression promoter.SOLUTION: An intestinal tract protectant according to the present invention contains agaro-oligosacchar...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MITANI TAKAKAZU, SAKAI TAKEHIKO, KARASAWA KOJI, NAKAMURA SOICHIRO, KATAYAMA SHIGERU, SHIRAI IKUYA
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a novel intestinal tract protectant and intestinal tract protection method, pharmaceutical, food and drink and tight junction-associated factor expression promoter.SOLUTION: An intestinal tract protectant according to the present invention contains agaro-oligosaccharide. An intestinal tract protection method according to the present invention uses the intestinal tract protectant containing agaro-oligosaccharide. A tight junction-associated factor expression promoter according to the present invention contains agaro-oligosaccharide.SELECTED DRAWING: Figure 1 【課題】新規の腸管保護剤及び腸管保護方法、医薬品、飲食品並びにタイトジャンクション関連因子発現促進剤を提供する。【解決手段】本発明に係る腸管保護剤は、アガロオリゴ糖を含有することを特徴とする。また、本発明に係る腸管保護方法は、前記アガロオリゴ糖を含有する腸管保護剤を使用することを特徴とする。また、本発明に係るタイトジャンクション関連因子発現促進剤は、アガロオリゴ糖を含有することを特徴とする。【選択図】図１